Your browser doesn't support javascript.
Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
Ader, Florence; Bouscambert-Duchamp, Maude; Hites, Maya; Peiffer-Smadja, Nathan; Mentré, France; Burdet, Charles.
  • Ader F; Département des Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse and Laboratoire de Virologie, Institut des Agents Infectieux de Lyon, Centre National de Référence des virus respiratoires France Sud, Hospices Civils de Lyon, 69004 Lyon, France; Université Claude Bernard Lyon 1, CIRI,
  • Bouscambert-Duchamp M; Virpath, Université Claude Bernard Lyon 1, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, Lyon, France.
  • Hites M; Cliniques Universitaires de Bruxelles-Hôpital Érasme, Université Libre de Bruxelles, Clinique des Maladies Infectieuses, Brussels, Belgium.
  • Peiffer-Smadja N; Université de Paris, IAME, INSERM, Paris, France; Service de Maladies Infectieuses et Tropicales, AP-HP, Hôpital Bichat, Paris, France; National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, L
  • Mentré F; Université de Paris, IAME, INSERM, Paris, France; Département d'Épidémiologie, Biostatistique et Recherche Clinique, AP-HP, Hôpital Bichat, Paris, France.
  • Burdet C; Université de Paris, IAME, INSERM, Paris, France; Département d'Épidémiologie, Biostatistique et Recherche Clinique, AP-HP, Hôpital Bichat, Paris, France.
Lancet Infect Dis ; 22(6): 764-765, 2022 06.
Article in English | MEDLINE | ID: covidwho-1864681

Full text: Available Collection: International databases Database: MEDLINE Main subject: Adenosine Monophosphate / Alanine / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Adenosine Monophosphate / Alanine / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article